Loading...
Loading...
Among the 8 tracked institutional investors we monitor, CCCC (C4 THERAPEUTICS INC) is held with a combined value of $32.87M across 13,696,550 shares. The largest holder is VANGUARD GROUP INC with a position worth $8.37M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 6 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$32.87M
Total Shares Held
13,696,550
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $8.37M | 0.00% | New |
| 2 | CITADEL ADVISORS LLC | $6.81M | 0.00% | +419.2% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $6.47M | 0.01% | +53.6% |
| 4 | BlackRock, Inc. | $5.39M | 0.00% | +4.0% |
| 5 | MILLENNIUM MANAGEMENT LLC | $3.66M | 0.00% | +17.2% |
| 6 | STATE STREET CORP | $1.01M | 0.00% | +11.7% |
| 7 | FMR LLC | $716.33K | 0.00% | +7.1% |
| 8 | Point72 Asset Management, L.P. | $444.72K | 0.00% | -98.2% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CCCC with a position worth $8.37M, representing 0.00% of their portfolio. In total, 8 institutional investors hold CCCC with a combined value of $32.87M.
In the most recent quarter, 1 fund opened a new position in CCCC. Additionally, 6 increased their holdings and 1 reduced their positions.
Institutional investors hold $32.87M worth of CCCC stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $8.37M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CCCC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CCCC positions.